Prostate Cancer
2023 Prostate Cancer Research Highlights
- Therapeutic Targeting of Neuroendocrine Prostate Cancer
- B7-H3 (CD276) as a Therapeutic Target in Lethal Prostate Cancers
- An International Registry to Inform Treatment Choices for Patients with Advanced Prostate Cancer
- Unique Structural Characterization of Androgen Receptor – A Key Protein in Prostate Cancer
Last updated Friday, September 15, 2023